Eleanor Dagostino - Concepedia

Author

Eleanor Dagostino

Pfizer (United States)

Also Known As

Eleanor Dagostino, Eleanor F. Dagostino

Publications

766

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)

About

Eleanor Dagostino is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	417
2	Pharmacology	5	5	375
3	Biochemistry	3	3	150
4	Natural Sciences	2	2	101
5	Molecular Biology	1	1	42

Eleanor Dagostino

Publications

755

Citations

H-Index

Page 1

	Year	Citations
Small-molecule p21-activated kinase inhibitor PF-3758309 is a potent inhibitor of oncogenic signaling and tumor growth Brion W. Murray, Chuangxing Guo, Joseph Piraino, Proceedings of the National Academy of Sciences	2010	318
Structure-based design of novel human Pin1 inhibitors (I) Chuangxing Guo, Xinjun Hou, Liming Dong, Bioorganic & Medicinal Chemistry Letters Molecular DockingDrug TargetMedicineRational Drug DesignStructure-based Design	2009	105
Structure-based design of novel human Pin1 inhibitors (II) Liming Dong, Joseph Marakovits, Xinjun Hou, Bioorganic & Medicinal Chemistry Letters Molecular DockingDrug TargetMedicineRational Drug DesignStructure-based Design	2010	86
Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds Gregory J. Crowther, Alberto J. Napuli, James H. Gilligan, Molecular and Biochemical Parasitology Antiparasitic AgentMedicineMalariaPharmacotherapyDrug Development	2010	76
Discovery of Pyrroloaminopyrazoles as Novel PAK Inhibitors Chuangxing Guo, Indrawan McAlpine, Junhu Zhang, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ChemistryBiochemistryMedicineTumor Growth	2012	59
Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket Chuangxing Guo, Xinjun Hou, Liming Dong, Bioorganic & Medicinal Chemistry Letters Phosphate Recognition PocketDrug TargetBiochemistryMedicinePharmacology	2014	49
The conformation of hepatitis C virus NS3 proteinase with and without NS4A: a structural basis for the activation of the enzyme by its cofactor Robert A. Love, Hans E. Parge, John Wickersham, Clinical and Diagnostic Virology Virus StructureViral ReplicationBiochemistryProtein FoldingNatural Sciences	1998	42
TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase Elena Brin, Katherine Wu, Eleanor Dagostino, Oncotarget	2018	20

Page 1